Editorial comment: diagnosis of acute HIV infection in hepatitis C treatment nonresponders--is extra vigilance required?
Golia
Preeti
P
Talal
Andrew
A
D000998:Antiviral Agents / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications* / Q000175:diagnosis*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D017211:Treatment Failure
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a